| ▲ | bonsai_spool an hour ago | |||||||
This comment makes no sense. Why would anyone make a drug if the current prevalent treatment was as good as a functional cure? What do lorbrena and keytruda have to do with the rate of failures being constant? | ||||||||
| ▲ | db48x 40 minutes ago | parent | next [-] | |||||||
These are examples of ambitious drugs that wouldn’t have been attempted even a few decades earlier. But technology improved and the money was there so they tried anyway, and found success. But for any 3 successes there are still 27 failures because those 27 were equally ambitious. | ||||||||
| ||||||||
| ▲ | s1artibartfast 24 minutes ago | parent | prev [-] | |||||||
Keytruda revenue is 30+ billion per year. If your new drug performs 1% better than Keytruda, that revenue becomes yours. If your drug perfroms 1% worse, you become a failure in the statistics. | ||||||||